Iwona Flisiak

prof. dr hab.med.

Medical University of Białystok

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Iwona Flisiak is a distinguished faculty member at the Medical University of Białystok, Poland. Her research focuses on dermatologic disorders, particularly psoriasis, and includes investigations into its pathogenesis and associations with metabolic syndrome. She has authored several notable articles that examine the role of proteins, metabolic disturbances, and treatment strategies within the context of psoriasis and related conditions.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Bartlomiej Lukaszuk

Assistant Professor

Medical University of Białystok

POLAND

View details

Anna Baran

Ass. Prof.

Medical University of Białystok

POLAND

View details

BARBARA MROCZKO

University Clinical Hospital In Bialystok

POLAND

View details

Agnieszka Miklosz

Medical University of Bialystok

POLAND

View details

Stefan Modzelewski

Medical University of Białystok

POLAND

View details

Justyna Hermanowicz

assistant professor

Medical University of Białystok

POLAND

View details

Agnieszka Owczarczyk‐Saczonek

POLAND

View details

Dariusz Pawlak

Medical University of Białystok

POLAND

View details

Hanna Mysliwiec

assistant professor

Medical University of Białystok

POLAND

View details

Anna Klimiuk

Medical University of Białystok

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Iwona Flisiak

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Psoriasis in the Context of Dermatologic Disorders: A Comprehensive Overview

The Role of Visfatin/NAMPT in the Pathogenesis of Psoriasis

Friend or foe? Sebaceous cyst inflammation during ixekizumab therapy in psoriatic arthritis: case based review

The Role of Selected Proteins in the Pathogenesis of Psoriasis

Is Atopic Dermatitis Associated with Systemic Metabolic Disturbances? A Systematic Review

The Association Between Psoriasis and Metabolic Syndrome in Children: A Narrative Review

Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature

Peripheral Kynurenine Pathway Metabolites in Patients with Psoriasis

Apolipoproteins in Psoriasis: The Effect of Acitretin Treatment and UVB Phototherapy

A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation

Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue

Enhanced Inflammation and Nitrosative Stress in the Saliva and Plasma of Patients with Plaque Psoriasis

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis

Lupus vulgaris of the auricle. = Gruźlica toczniowa małżowiny usznej.

Methotrexate decreases the level of PCSK9 - A novel indicator of the risk of proatherogenic lipid profile in psoriasis. The preliminary data.

Salivary antioxidants and oxidative stress in psoriatic patients: can salivary total oxidant status and oxidative status index be a plaque psoriasis biomarker?

Collaborators (10)

Bartlomiej Lukaszuk

Anna Baran

BARBARA MROCZKO

Agnieszka Miklosz

Stefan Modzelewski

Justyna Hermanowicz

Agnieszka Owczarczyk‐Saczonek

Dariusz Pawlak

Hanna Mysliwiec

Anna Klimiuk

Make your next move.